[EN] 6-AZA-QUINOLINE DERIVATIVES AND RELATED USES [FR] DÉRIVÉS DE 6-AZA-QUINOLÉINE ET UTILISATIONS ASSOCIÉES
摘要:
The present disclosure relates compounds of Formula (0): and pharmaceutically acceptable salts and stereoisomers thereof. The present disclosure also relates to methods of preparing the compounds, compositions comprising the compounds, and methods of using the compounds, e.g., in the treatment of cancer.
Direct Synthesis of Fluorinated Heteroarylether Bioisosteres
作者:Qianghui Zhou、Alessandro Ruffoni、Ryan Gianatassio、Yuta Fujiwara、Eran Sella、Doron Shabat、Phil S. Baran
DOI:10.1002/anie.201300763
日期:2013.4.2
direction: A modular synthesis of reagents (e.g. sodium difluoroethylsulfinate) that can be used for the direct incorporation of difluoroalkyl groups onto heterocycles is reported. The scope and generality of the incorporation of difluoroalkyl groups is exemplified with the difluoroethyl group and a proof of principle is shown for a general synthesis of fluorinated heteroarylether bioisosteres.
[EN] INHIBITORS OF RAF KINASES<br/>[FR] INHIBITEURS DE KINASES RAF
申请人:KINNATE BIOPHARMA INC
公开号:WO2023070053A1
公开(公告)日:2023-04-27
Provided herein are inhibitors of receptor tyrosine kinase effector, RAF, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.
[EN] 6-AZA-QUINOLINE DERIVATIVES AND RELATED USES<br/>[FR] DÉRIVÉS DE 6-AZA-QUINOLÉINE ET UTILISATIONS ASSOCIÉES
申请人:[en]BLACK DIAMOND THERAPEUTICS, INC.
公开号:WO2023039505A1
公开(公告)日:2023-03-16
The present disclosure relates compounds of Formula (0): and pharmaceutically acceptable salts and stereoisomers thereof. The present disclosure also relates to methods of preparing the compounds, compositions comprising the compounds, and methods of using the compounds, e.g., in the treatment of cancer.